Weight Management News and Research

RSS

Dietitians boost GLP-1 therapy success with personalized care and side effect management

Researchers reveal the importance of personalized communication and side effect management in improving outcomes for patients on GLP-1 medications for weight management. The study highlights the critical role of dietitians in guiding lifestyle and dietary changes.

15 Oct 2024

Semaglutide improves heart health and reduces weight in obese patients, but with side effects

Semaglutide significantly reduces cardiovascular events and adverse effects in overweight and obese patients. The study highlights semaglutide's superiority over other GLP-1 agonists for cardiovascular health.

14 Oct 2024

UPenn PRC receives $6.5 million grant for community health solutions

The University of Pennsylvania Prevention Research Center (UPenn PRC) has been awarded a grant totaling $6.5 million over five years from the Centers for Disease Control and Prevention (CDC) to work with communities in the Philadelphia area to develop, test, and evaluate solutions to public health problems, with a particular focus on cancer.

14 Oct 2024

Can the Mediterranean diet protect against childhood overweight and obesity?

Following the Mediterranean diet may modestly lower children's risk of gaining excessive weight, but the impact was not statistically significant after adjusting for baseline factors. Specific foods like nuts and vegetables offer some protection against large BMI increases.

13 Oct 2024

GLP-1 drugs protect brain health by improving neurovascular function and reducing inflammation

Research highlights how GLP-1 receptor agonists may improve brain health by targeting the neurovascular unit, linking metabolic health to cognitive function. It suggests potential therapies for neurodegenerative diseases like Alzheimer's.

7 Oct 2024

Maternal obesity doubles the risk of developing autism in children

Researchers investigate the potential relationship between maternal fat mass and long-term mental health issues in children born to these mothers.

26 Sep 2024

Targeted obesity programs reduce lipid-related heart disease risk in children

Researchers assess the lipid profiles of obese children and adolescents and their health implications.

24 Sep 2024

Medicare coverage for obesity drug raises questions

Millions of older Americans with obesity could potentially get Medicare's help with the hefty price of a weight-loss medication in order to reduce their high risk of heart problems.

23 Sep 2024

Excess body weight at first cancer diagnosis increases risk of second cancer

Adults with excess body weight at their first cancer diagnosis face a higher risk of developing a second primary cancer, particularly those related to obesity, according to a recent study. The research emphasizes the need for survivorship guidelines targeting weight management.

22 Sep 2024

Ketogenic diet restores menstrual cycles and boosts fertility in women with PCOS

A ketogenic diet restored menstrual cycles in all women with PCOS in a study, with over half of those desiring pregnancy achieving it. The diet could be a promising approach to enhance fertility.

15 Sep 2024

GLP-1 receptor agonists show promise in treating substance use disorders

A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are inconsistent due to study variability and patient differences.

9 Sep 2024

Good heart health during early pregnancy may reduce genetic risk of preeclampsia and hypertension

Maintaining good cardiovascular health during the first trimester of pregnancy may offset the genetic risk of developing preeclampsia and/or gestational hypertension, according to preliminary research presented at the American Heart Association's Hypertension Scientific Sessions 2024.

9 Sep 2024

New hydrogel system could extend semaglutide dosing to once a month for type 2 diabetes patients

French researchers have developed a new drug delivery system that could cut the dosing schedule for the type 2 diabetes and weight control drug semaglutide to just once a month, according to new research to be presented at this year's annual meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).

9 Sep 2024

Semaglutide does not increase risk of depression or suicidal thoughts

Taking the weight loss medication semaglutide did not increase the risk of depressive symptoms, suicidal thoughts, or suicidal behavior in persons without known major mental health disorders, according to a new study led by researchers from the Perelman School of Medicine at the University of Pennsylvania published this week in JAMA Internal Medicine.

4 Sep 2024

Study reassures patients about semaglutide safety

4 Sep 2024

Tirzepatide outperforms insulin in controlling diabetes and promoting weight loss in clinical trials

Tirzepatide, a once-weekly dual agonist, outperforms long-acting insulin in reducing HbA1c, body weight, and improving cardiovascular markers in Type 2 diabetes patients.

2 Sep 2024

Obesity increases the risk of SARS-CoV-2 infection by 34%

Obesity is linked to a 34% higher risk of SARS-CoV-2 infection upon exposure, highlighting the importance of weight management in COVID-19 prevention.

30 Aug 2024

Primary care providers key to addressing emotional eating

Primary care providers are well positioned to address emotional eating because of their long-term relationships with patients, noted Jana DeSimone Wozniak, PhD and Hsiang Huang, MD, MPH, of Harvard Medical School and Cambridge Health Alliance in Cambridge, Massachusetts.

28 Aug 2024

Improved IVF success with the Mediterranean diet, study shows

Review highlights that adherence to the Mediterranean diet may improve clinical pregnancy and live birth rates in couples undergoing assisted reproduction, though findings are inconsistent, and more research is needed.

27 Aug 2024

Clarification urgently needed for detected signal of semaglutide-linked suicidal ideation

Researchers investigate the potential link between the obesity drugs semaglutide and liraglutide and suicidal or self-injurious adverse drug reactions.

26 Aug 2024

Weight Management News and Research

Dietitians boost GLP-1 therapy success with personalized care and side effect management

Semaglutide improves heart health and reduces weight in obese patients, but with side effects

UPenn PRC receives $6.5 million grant for community health solutions

Can the Mediterranean diet protect against childhood overweight and obesity?

GLP-1 drugs protect brain health by improving neurovascular function and reducing inflammation

Maternal obesity doubles the risk of developing autism in children

Targeted obesity programs reduce lipid-related heart disease risk in children

Medicare coverage for obesity drug raises questions

Excess body weight at first cancer diagnosis increases risk of second cancer

Ketogenic diet restores menstrual cycles and boosts fertility in women with PCOS

GLP-1 receptor agonists show promise in treating substance use disorders

Good heart health during early pregnancy may reduce genetic risk of preeclampsia and hypertension

New hydrogel system could extend semaglutide dosing to once a month for type 2 diabetes patients

Semaglutide does not increase risk of depression or suicidal thoughts

Study reassures patients about semaglutide safety

Tirzepatide outperforms insulin in controlling diabetes and promoting weight loss in clinical trials

Obesity increases the risk of SARS-CoV-2 infection by 34%

Primary care providers key to addressing emotional eating

Improved IVF success with the Mediterranean diet, study shows

Clarification urgently needed for detected signal of semaglutide-linked suicidal ideation

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News